Arda Ural, Ph.D., is the Americas Industry Markets Leader for Health Sciences and Wellness at Ernst & Young LLP (EY). Arda oversees the life sciences team that covers industry mergers and acquisitions.
Navigating the Recession and Patent Expirations
Pharma is built to overcome, but focus on fundamentals remains key.
Positive Outlook for Post-Pandemic Biotech
A recent analysis of the biotech market shows promising signs.
Biopharma Q1 Earnings: The Impact of COVID-19
The recent flurry of Q1 earnings reports offer a unique opportunity to assess the real-time impacts of COVID-19 on the sector.
Leading Through a Historical Singularity
Considerations for biopharma to transform itself beyond the COVID-19 crisis, by Arda Ural.
2 Commerce Drive Cranbury, NJ 08512